Hot Off The Press!

Issa and Chinmay cover Novartis' acquisitions in 1st Half of 2026.

Novartis has picked up Tourmaline Bio, Avidity Biosciences, Pikavation Therapeutics, Excelergy, and Myricx Bio.

Tune in to hear about what it all means for Novartis, and for the industry.

Issa and Chinmay cover Eli Lilly's acquisitions in 1st Half of 2026.

Eli Lilly has spent nearly $32B for 13 companies so far this year. These include Centessa Pharmaceuticals, Kelonia Therapeutics, Ventyx Biosciences, and AtaiBeckley.

Be sure to listen through the end for the addition on Merida Biosciences, and other latest acquisitions.

Hot Off The Press!

Issa and Chinmay cover Merck Group and Merck & Co.'s acquisitions in 1st Half of 2026. Merck's buying spree has included JSR Life Sciences, Bio-Techne, Terns Pharmaceuticals, and Cidara Therapeutics. What do these acquisitions mean for Merck and the industry? Listen in.